Platinum dose-intensity in solid tumors: pharmacological and clinical perspectives.
Pagani
O
O
Division of Oncology, Ospedale San Giovanni, Bellinzona, Switzerland.
Sessa
C
C
Cavalli
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage* / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010051:Ovarian Neoplasms / Q000188:drug therapy; D012189:Retrospective Studies; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000188:drug therapy
D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D016190:Carboplatin; D002945:Cisplatin